"My opinion again is that they wouldn't release funds for 2 trials on the same drug (when the first trial isn't over) if they didn't have some 'confidence' with it."
----
I know of a drug that the US Dept of Defense funded $180 million for US trials recently despite that drug having a history of safety suspensions as well as being stuck in regulatory limbo in Japan for 3 years.
My point is, when it comes to third party funding or validation, I'd place greater weighting to Big Pharma over government. Government aren't as commercially orientated so may have a higher threshold for failure. There's also the perception the best brains are in the private sector.
neu investor presentation, page-22
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.38 |
Change
-0.270(1.98%) |
Mkt cap ! $1.710B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.11 | $4.283M | 320.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $13.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.40 | 3328 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |